News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Eric G. Klein, PharmD

Articles by Eric G. Klein, PharmD

Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective

ByEric G. Klein, PharmD,Joseph A. Paladino, PharmD

October 1st 1996

Latest Updated Articles

Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective
Published: October 1st 1996 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text